Royalty Pharma Collection Trust
Records under this name other than patents Royalty Pharma Collection Trust holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Royalty Pharma Collection Trust
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,994,220 | Milnacipran for the Long-Term Treatment of Fibromyalgia Syndrome Formerly held In force · High confidence | In force | High confidence | |
| US 7,816,325 | Secondary binding site of dipeptidyl peptidase IV (DP IV) Term ended Term ended Jun 19, 2025 · From the USPTO record | Term ended | Term ended Jun 19, 2025 | From the USPTO record |
| US 6,602,911 | Methods of treating fibromyalgia Formerly held Term ended Term ended Jan 14, 2023 · From the USPTO record | Term ended | Term ended Jan 14, 2023 | From the USPTO record |
| US 6,677,465 | Method for the enantioselective preparation of 3,3-diphenyl-2,3-epoxy propionic acid esters Term ended Term ended Oct 29, 2022 · From the USPTO record | Term ended | Term ended Oct 29, 2022 | From the USPTO record |
| US 7,820,643 | Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain Formerly held Term ended Term ended May 12, 2022 · From the USPTO record | Term ended | Term ended May 12, 2022 | From the USPTO record |
| US 6,992,110 | Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain Formerly held Term ended Term ended Nov 17, 2021 · From the USPTO record | Term ended | Term ended Nov 17, 2021 | From the USPTO record |
| US 6,635,675 | Method of treating chronic fatigue syndrome Formerly held Term ended Term ended Nov 12, 2021 · From the USPTO record | Term ended | Term ended Nov 12, 2021 | From the USPTO record |
| US 7,888,342 | Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain Formerly held Term ended Term ended Nov 5, 2021 · From the USPTO record | Term ended | Term ended Nov 5, 2021 | From the USPTO record |
| US 7,915,246 | Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain Formerly held Term ended Ended no later than Nov 5, 2021 · From the USPTO record | Term ended | Ended no later than Nov 5, 2021 | From the USPTO record |
| US 6,559,338 | Method for racemate splitting of 2-hydroxypropionic acids Term ended Term ended Apr 25, 2021 · From the USPTO record | Term ended | Term ended Apr 25, 2021 | From the USPTO record |